CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XIX. A NOTE ON THE USE OF FIBRINOGEN AND THROMBIN IN THE SURFACE TREATMENT OF BURNS

^{Department of Pathology, Harvard Medical School, Boston}

^{Department of Physical Chemistry, Harvard Medical School, Boston}

Lieutenant, United States Naval Reserve.

Welch Fellow in Internal Medicine of the National Research Council, Member, Society of Fellows, Harvard University, during the first year of these investigations.

This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions or assertions contained herein are the private ones of the writers and are not to be construed as official or reflecting the views of the Navy Department or the Naval Service at large.

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 24 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Hawn, C. in: PubMed | Google Scholar

^{Department of Pathology, Harvard Medical School, Boston}

^{Department of Physical Chemistry, Harvard Medical School, Boston}

Lieutenant, United States Naval Reserve.

Welch Fellow in Internal Medicine of the National Research Council, Member, Society of Fellows, Harvard University, during the first year of these investigations.

This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions or assertions contained herein are the private ones of the writers and are not to be construed as official or reflecting the views of the Navy Department or the Naval Service at large.

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 24 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Bering, E. in: PubMed | Google Scholar

^{Department of Pathology, Harvard Medical School, Boston}

^{Department of Physical Chemistry, Harvard Medical School, Boston}

Lieutenant, United States Naval Reserve.

Welch Fellow in Internal Medicine of the National Research Council, Member, Society of Fellows, Harvard University, during the first year of these investigations.

This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions or assertions contained herein are the private ones of the writers and are not to be construed as official or reflecting the views of the Navy Department or the Naval Service at large.

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 24 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Bailey, O. in: PubMed | Google Scholar

^{Department of Pathology, Harvard Medical School, Boston}

^{Department of Physical Chemistry, Harvard Medical School, Boston}

Lieutenant, United States Naval Reserve.

Welch Fellow in Internal Medicine of the National Research Council, Member, Society of Fellows, Harvard University, during the first year of these investigations.

This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions or assertions contained herein are the private ones of the writers and are not to be construed as official or reflecting the views of the Navy Department or the Naval Service at large.

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 24 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Armstrong, S. in: PubMed | Google Scholar